Field Poll: California Nurses Association Most Favorably Viewed Group in Healthcare Arena
High Approval Ratings Consistent with Public's Support of 'Medicare for All' or Single-payer Healthcare
OAKLAND, Calif., May 1 /PRNewswire-USNewswire/ -- With talk of a new
effort to enact healthcare reform surfacing in Sacramento, a new field poll
this week illustrates that...
Isis Favorably Revises Financial Guidance and Introduces Mipomersen as Generic Name for ISIS 301012
- ISIS 301012 given generic name mipomersen sodium
- Isis further reduces its 2007 net operating loss guidance to mid to high $20 million range - Isis will host a conference call this morning at 8:00 a.m. E.T. at http://www.isisph...
Cambrex Reports Second Quarter 2009 Results
...er over quarter.
Second quarter 2009 Gross Margin increased to 32.9% of sales from 29.9% during the second quarter 2008, with foreign currency favorably
impacting gross margin by 2.1%. Favorable product mix and cost reductions were the main drivers of the higher margins. This was partially offset by ...
Nutraceutical Reports Fiscal 2009 Q3 Results and Expands Share Repurchase Program
...pany. We expect acquisitions to contribute to profitability and cash flow within this calendar year. It is encouraging that the market has responded favorably
to the Company's recent addition to the Russell 2000 stock index and we believe our financial strength and position as a value based stock will bring ...
WellPoint Reports Second Quarter 2009 Results
...n health care utilization. The Company is refining its product offerings, expanding membership retention programs and implementing pricing actions to favorably
impact its Local Group business.
Consumer Business: Operating gain for the Consumer Business segment was $382.1 million in the second quarter...
Most Not Worried by Delayed Prostate Cancer Therapy
The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably
low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.
Men who were in poor general health a...
Study finds acceptable levels of anxiety among men living with early, untreated prostate cancer
...A total of 129 questionnaires were completed and returned an average of 2.7 months after diagnosis. More than 80 percent of the 129 respondents scored favorably
low on the parameters measured. Patients' scores were comparable or favorable to scores of men (reported in other studies) who underwent treatment for...
Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance
...penses were essentially flat at $1.708 billion. These results were impacted favorably
by the movement of foreign exchange rates and a reduction in advertising ex...ge rates, partially offset by increased demand. Demand outside the U.S. was favorably
impacted by the withdrawal of generic competition in Germany.
Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009
... exceeded the pre-specified endpoint needed to expand the trial and compare favorably
with historical data with chemotherapy alone. Recent analysis shows the me...xceeded the pre-specified endpoint needed to expand the trial, compare very favorably
with historical data with chemotherapy alone and are especially encouraging...
Local Heart Doctors First in Nation to Announce Active Investigation of Red Wine (Resveratrol) Pills, Issue Consumer Precautions
...re resveratrol, a molecule that has produced strikingly positive effects in animal studies. Resveratrol inhibits blood clots, reduces inflammation and favorably
alters cholesterol, among its many beneficial properties.
Red wine molecules pre-condition the heart
Dr. Lebowitz says, in animals, resve...
Favorably in Medical Technology
Definitive Outcomes of Radiofrequency Ablation for Barrett's Esophagus Using the HALO Ablation System Reported at the Digestive Disease Week Meeting for Gastroenterologists and Esophageal Surgeons
... Radiofrequency ablation is durable after 2 years, compares favorably
with endoscopic resection for advanced disease, and reduces the risk for cancer progression
SUNNYVALE, Calif., June 3 /PRNewswire/ -- Results f...
Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials
... the pre-specified endpoint needed to expand the trial, compare
with historical data with chemotherapy alone and are
especially enco...e pre-specified
endpoint needed to expand the trial and compare very favorably
historical data with chemotherapy alone. Recent analysis also ...
CuraGen Updates CR011-vcMMAE Data at ASCO
... appeared to correlate with favorable outcome.
"These Phase II results show evidence of activity in patients with advanced melanoma that compares favorably
to activity seen with other currently used treatments for these patients, who are in need of additional options," commented Dr. Simantov.
Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401's Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
...Institute, stated, "perifosine demonstrated impressive single agent activity with an overall partial response rate of greater than 10%, which compares favorably
to that of mTOR inhibitors, and was well tolerated. We are particularly intrigued by the group of patients previously treated with both an mTOR and V...
Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientific's TAXUS(R) Liberte(R) Stent
...seem to be important differences between different brands of DES."(1)
"The results of this study are noteworthy for TAXUS Liberte, which compared favorably
in rates of repeat procedures to both 'olimus stents," said Donald S. Baim, M.D., Chief Medical and Scientific Officer of Boston Scientific. "The fin...
Cardium Announces Completion of Patient Recruitment in Phase 2b Clinical Trial of Excellarate(TM) for the Potential Treatment of Diabetic Foot Ulcers
...r will effectively accelerate the business or market, that product modifications or launches will be successful or that the resulting products will be favorably
received in the marketplace, that our products or product candidates will prove to be sufficiently safe and effective after introduction into a broade...
Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients
... cohort. Ten of the 14 evaluable patients in this cohort demonstrated an objective tumor response according to RECIST criteria. These results compare favorably
with historical response rates for docetaxel as solo therapy in advanced breast cancer patients and exceeded the pre-specified primary efficacy endpoi...
An Independent Study Reports on the Utility of ImmuKnow(R), the Cylex(TM) Immune Cell Function Assay, for Monitoring Heart Transplant Recipients
...ermine whether ImmuKnow assay values can be correlated with the incidence of infection or rejection.
The lead investigator, Jon Kobashigawa, MD, favorably
remarked, "These results suggest that ImmuKnow as a non-invasive immune monitoring is indeed a promising means for individualizing immunosuppression i...
Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
...ctive tumor responses needed to expand the trial to the larger cohort."
Mr. King added, "The tumor response data to date from this trial compares favorably
to published studies with current standard-of-care lung cancer treatments, and we are looking forward to seeing results from the entire study. With d...
Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
... and completed in an efficient and successful manner, that product modifications or launches will be successful or that the resulting products will be favorably
received in the marketplace, that our products or proposed products will prove to be sufficiently safe and effective, that necessary regulatory approv...
Favorably in Medical Products
AMO Vitrax (sodium hyaluronate) viscoelastic solution
Features:...ntains anterior chamber depth for sate, ample working room
Ensures optimal protection of endothelial cells
Requires no refrigeration
with other adhesive viscoelastics...
Company:Advanced Medical Optics, Inc.
Favorably in Medical Definition
... Another reason for the scepticism of the pharmaceutical industry is the threat to existing products. Many blockbuster drugs, such as Lipitor, compare favorably
with cheaper generic drugs only in a small percentage of patients. But since it is not known how to identify these, many physicians prescribe the expe...
Favorably in Medical Dictionary
...y cough up tuberculosis ... A naso- gastric tube is placed through the nose into your child's stomach. ... Isolated gastric bypass compares favorably
with biliopancreatic diversion in ... The pouch side was oversewn with PDS suture, and the gastric side was inverted. ... Gastric bypass surg...
Favorably in Biological News
Can a new implant coating technique create a new six million dollar man?
...ochemical Society in San Francisco in May 2009. In addition, a new 12-week implantation study, recently published in the journal Acta Biomaterialia , favorably
compared the performance of the Tel Aviv University coatings to those of current commercial coatings.
Giving your joints an electrochemical bath ...
A Canada-wide technology platform for mapping the human interactome
...raction networks underlying the functioning of our cells. The creation of a nation-wide platform will allow Canadian scientists to position themselves favorably
in interactome research. In fact, a group of Canadian researchers led by Dr. Coulombe is currently working with American and European colleagues on th...
New drug shows promise in treating drug-resistant prostate cancer
...the multisite Phase 1/2 trial designed to evaluate safety, 22 showed a sustained decline in PSA levels, an indication that their cancer was responding favorably
to the drug. This trial is still underway, and results from a total of 140 patients receiving higher doses of the drug will be reported within the nex...
New medications show promise in treating drug-resistant prostate cancer
...y-two of those men showed a sustained decline in their blood levels of prostate specific antigen (PSA), an indication that their cancer was responding favorably
to the drug. This trial is still under way, and results from a total of 140 patients receiving higher doses of the drug will be reported within the ne...
Interventional treatment can be recommended as first-line treatment for 'silent killer'
...cted by surveillance imaging. "Most importantly, the overall rate of secondary interventions after endovascular repair was 7.2 percent, which compares favorably
to open surgery series," said Sabharwal. Complications include possible movement of the graft after treatment or persistent blood flow into the aneury...
Studies examine genetic determinants of ADHD
...olleagues, examined genetic markers across the entire human genome to search for genes that may someday be used to predict which children respond most favorably
to the stimulant medications used to treat ADHD. It demonstrated that, although there are likely to be genetic factors that are associated with stimul...
New dummy design and development wins US Department of Defense award
...isk due to behind-armor effects or novel threats. This device will allow the development of standards for eye and face protection devices and has been favorably
tested in explosive environments to characterize blast injury.
"In addition to benefiting the military, it is exciting to note that the FOCUS head...
Phase III data show efficacy/safety of iclaprim in patients with complicated skin infections
...e bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). In addition, iclaprim was well-tolerated with a safety profile that compared favorably
to linezolid. A New Drug Application for intravenous iclaprim in cSSSI will be discussed at the meeting of the U.S. Food and Drug Administration Anti-...
'Buckyballs' have high potential to accumulate in living tissue
...balls would be partitioned.
"The bottom line is, if buckyballs partition favorably
from water to octanol, they are also likely to partition favorably
from water to fatty tissues," Jafvert said.
The researchers also are inv...
Experimental chemotherapy regimen shows promise in treating advanced lung cancer
...rapy was 28 percent, median progression-free survival was 4.9 months and median overall survival was 15 months.
Okamoto says these findings compare favorably
with previous studies of platinum-based doublets, which demonstrated response rates of 17 to 33 percent, a median time to progression or progression-f...
Favorably in Biological Technology
Repligen Reports First Quarter Fiscal Year 2010 Financial Results
...000 for the first quarter of fiscal year 2009. The prior year results were favorably
impacted by a one-time payment of $6,330,000 by Bristol-Myers Squibb Compan...2009 of $8,279,000 or $0.26 per diluted share. The prior year results were favorably
impacted by back royalty payments of $6,330,000 from Bristol-Myers Squibb o...
Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress
The company expects continued progress in reimbursement to favorably
impact product revenue; net loss to narrow in the second half of 2009 as co...mercialization; the company's expectation that improved pricing yields will favorably
impact product revenue; the company's expectations regarding full year 2009...
Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009
...those associated with the purchase, during the quarter, of additional shares in Matrix. Both SG&A and R&D expense in the current quarter were favorably
impacted by the effect of the stronger U.S. dollar and by synergies realized as a result of the company's ongoing restructuring initiatives.
Sunesis Reports Financial Results for the Second Quarter 2009
... a voreloxin dose of 80 mg/m2 or higher. Five of 14 of these patients achieved a CR or CRp for an overall CR or CRp rate of 36 percent, which compares favorably
relative to expected remission rates in this AML population of approximately 10 to 15 percent. In the Bolus Schedule, both first relapse and primary r...
Cardium's InnerCool Therapies Business to Be Acquired By Royal Philips Electronics
...temperature modulation business or expand its market, that product modifications or launches will be successful or that the resulting products will be favorably
received in the marketplace, that our products or proposed products will prove to be sufficiently safe and effective, that our products or product can...
Glenmark's Novel Molecule for Diabetes, Melogliptin to Enter Phase III Trials
... with a mean
average reduction of 0.88 % and 1.05 % in patients receiving 100mg once daily
dose and 50mg twice daily dose respectively, which compares favorably
reported results of other DPP-4's.
The Phase IIb results for Melogliptin demonstrate potential for offering
class leading improvements in gl...
YM BIOSCIENCES REPORTS DAIICHI-SANKYO ENROLLS FIRST PATIENTS IN PHASE II, FIRST-LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB
...d to the toxicities of either regimen, with no Grade III/IV skin toxicities observed. The trial demonstrates that the efficacy of nimotuzumab compares favorably
to results reported for cetuximab, an EGFR-targeting antibody marketed as Erbitux(R), but that this efficacy was not accompanied by the severe toxicit...
AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia
..., as the continuation rate of patients into the open-label part of the study remains at over 90% of those eligible to continue at week 52 and compares favorably
with those reported by others.(1) We look forward to presenting the data from the double-blind portion of the study in the next quarter."
Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting
...breast cancer were enrolled in the first cohort. The 71% objective tumor response rate seen in the 14 evaluable patients in the first cohort compares favorably
with historical response rates for docetaxel as solo therapy in advanced breast cancer patients and it exceeded the pre-specified primary endpoint nee...
NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD & NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS
...nstrates that the efficacy of nimotuzumab compares favorably
to results reported for cetuximab, an EGFR-targeti...The response rates observed by the authors compare favorably
with previous studies of cetuximab in combination ...as statistically superior to CRT arm, and compares favorably
with historical controls performed in Western coun...